tabletter
Sponsors
Karolinska University Hospital, Gentofte Hospital, Odense University Hospital, Helse Bergen HF, Rigshospitalet
Conditions
Acute interstitial nephritisBacterial infectionCardiovascular diseaseChronic back painComorbid dependencies to benzodiazepines and opioidsGram-negative BacteremiaHypertensionMigraine
Phase 2
Repurposing colchicine for reduction of residual inflammatory risk in type 1 diabetes (REC1TE): a randomized, double-blind, placebo-controlled, investigator-initiated trial
Active, not recruitingCTIS2022-502038-23-00
Start: 2023-08-25Target: 100Updated: 2024-07-26
A Randomized Trial of Trastuzumab Deruxtecan and Biology-Driven Selection of Neoadjuvant Treatment for HER2-positive Breast Cancer: ARIADNE
RecruitingCTIS2022-501504-95-00
Start: 2023-06-23Target: 402Updated: 2025-08-18
The COlchicine HypERtENsion Trial
CompletedCTIS2024-511391-32-00
Start: 2021-08-10End: 2026-01-09Target: 150Updated: 2024-07-10
Acute Effects of Partial GABA(A)-Receptor Modulation by GT-002 on Psychophysiological Measures: The TOTEMS Phase II Clinical Trial Targeting Cognitive Impairment Associated with Schizophrenia
Not yet recruitingCTIS2024-519389-28-00
Target: 50Updated: 2025-02-14
Phase 3
Melatonin for Chronic back pain (The MOCHA trial)
RecruitingCTIS2023-503530-41-00
Start: 2024-11-07Target: 220Updated: 2024-11-18
Benzodiazepine stabilizing treatment for patients with benzodiazepine dependence undergoing opioid agonist therapy (BMX-BAR)
RecruitingCTIS2023-510404-44-02
Start: 2022-10-02Target: 108Updated: 2025-07-07
Prevention and Treatment of Episodic migraine by Cabergoline Therapy (PROTECT)
A randomized, placebo-controlled, double-blind, investigator-initiated trial
RecruitingCTIS2025-522323-10-00
Start: 2025-11-12Target: 150Updated: 2025-12-09
Phase 4
Short course antibiotic treatment of Gram-negative bacteremia: A multicenter, randomized, non-blinded, non-inferiority interventional study
RecruitingCTIS2024-514900-16-00
Start: 2024-07-25Target: 380Updated: 2025-09-12
REPLACE - A multi-centre, randomised, double-blinded, placebo controlled 16-weeks study to compare the effect of hydrocortisone and placebo in patients with Giant Cell Arteritis (GCA)/ Polymyalgia Rheumatica (PMR) with patient-reported symptoms of adrenal insufficiency after cessation of glucocorticoid treatment.
RecruitingCTIS2024-513822-53-00
Start: 2022-02-01Target: 270Updated: 2024-07-31
REINFORCE – Reducing infection-related readmissions following cystectomy. A multicentre randomised clinical trial testing superiority of individualised targeted antibiotic prophylaxis over empiric prophylaxis at ureteral stent removal to reduce infection-related readmissions following cystectomy.
RecruitingCTIS2024-514312-27-00
Start: 2025-01-07Target: 248Updated: 2024-12-10
Prednisone treatment in acute interstitial nephritis - a randomized prospective trial (PRAISE)
RecruitingCTIS2024-520299-86-00
Start: 2025-01-22Target: 110Updated: 2025-10-10
Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia:
A randomized, non-blinded, non-inferiority interventional study
RecruitingCTIS2024-519186-21-01
Start: 2025-01-30Target: 264Updated: 2025-11-17
Pharmacokinetics and pharmacodynamics of intravenous versus enteral amiodarone in critically ill patients with new-onset atrial fibrillation – a randomised controlled pilot trial
RecruitingCTIS2025-521289-88-02
Start: 2025-09-01Target: 50Updated: 2025-06-06